MAPT and Alzheimer disease: Melatonin not only increased survival rates in transgenic AD mice, but also reversed Aβ-induced synaptic disorder, memory deficit, neurodegeneration, as well as phosphorylation of tau in wild-type mice injected with Aβ peptides [356,357,358,359,360,361,362,363,364,365,366] (Table 2).